Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology at Montefiore Health System, shared a post on X:
“Proud to share our latest work from Montefiore Health System
Albert Einstein College of Medicine – Official examining molecular testing in early-stage lung adeno. Comprehensive NGS revealed important differences in EGFR and KRAS subtypes in our diverse patient population, reinforcing why equitable testing and trials matter.”
Title: Who Gets Left Out of Precision Oncology? Real-World Driver Mutation Expression Patterns and Therapeutic Eligibility in a Diverse Single-Center Early-Stage Lung Adenocarcinoma Cohort
Authors: Grace Ha, Lesly Diaz Chacha, Lesley Coe, Sophia Yanis, Isaac Faith, Frederick Vasquez, Jason Duodu, Marc Vimolratana, Neel P. Chudgar, Haiying Cheng, Balazs Halmos, H. Dean Hosgood, Brendon M. Stiles, Tamar Nobel
Other articles about Lung Cancer on OncoDaily.
